- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
Industry Analysis Health Care biotechnology One-on-One's Investment economy biotech industry PUBLIC BIOTECH - Stats economic development patent Biotechnology Industry FDA Partnering 2012 BIO International Convention BIO International Convention IPO Events PUBLIC BIOTECH - Stock performance BIOTECH drug developmentAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Category Archives: Business and Investments
Latest From Business and Investments
A Matter of Economics; OK Gov Fallin Talks Biotech
A few weeks ago Sheri Stickley, President of the Oklahoma Bioscience Association guest blogged about her experience at the 2011 BIO International Convention. As I have mentioned before, this year’s event drew more than 100 public officials and 11 U.S. Governors. We were particularly honored to have several Governors attend our event for the first time. Among them was Oklahoma Governor Mary Fallin. Like many other public officials, she traveled to the convention to publicize Read More >
How to Stand Out From the Crowd; Promoting Oklahoma Bioscience
BIO’s annual International Convention has emerged as a must-attend event for countries, states and regions that are hungry for industry investment. The convention gives them the ideal platform to publicize and promote what they have to offer to industry leaders in terms of economic development opportunities. International and domestic public officials take the time to attend because they recognize the enormous potential of the industry. This year’s event drew more than 100 public officials and Read More >
State Deficits to Shrink & Taxes Drop – Good News for Biotech
Forecasters at the National Conference of State Legislatures’ 2011 Legislative Summit expect a dramatic reduction of state deficits in the coming years, along with business-friendly tax-cuts. The projections are based on a survey of budget officials in all 50 states last month, said Corina Eckl, director of state services for NCSL. Eckl also noted an emerging trend in which state governors and legislatures are allowing for the expiration of temporary business taxes. Notably, the Michigan Business Read More >
South Dakota Governor Dennis Daugaard Talks Biotech
Shortly before the 2011 BIO International Convention, I had the opportunity to speak with South Dakota Governor Dennis Daugaard about his state’s growing biotech presence and his first visit to the world’s largest global event for the biotechnology industry. South Dakota Governor Dennis Daugaard Click the link below to listen to the podcast interview with Governor Daugaard. South Dakota Governor Dennis Daugaard Talks Biotech On a similar note, J. Pat Costello of South Dakota Governor’s Office of Economic Read More >
Rust Belt Renaissance; Biotech in the Buckeye State
Once upon a time in America there was a broad region known as the Manufacturing Belt, it followed the Great Lakes from New York to Wisconsin. These days you generally hear it called the Rust Belt. Despite the loss of hundreds of thousands of jobs, it remains one of the world’s preeminent manufacturing areas with a workforce that has been retooled to participate in an innovation economy. Amid the sea of grim employment numbers and Read More >
